New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (565)	11/2/2002 3:20:43 PM
From: scaram(o)uche	Read Replies (1) of 724

DGI is probably in trouble. It boils down to Novo and how hot the insulin/IGF-1 data is. A company can survive this liquidity crunch, but..... it's not likely that 2000/2001 valuations can be sustained. In 2000, it was easy to factor a good chunk for Axiom into KDUS valuations. They just went to SQNM for about a nickle. That was Freedman's/Eichenbaum's only mistake.... they needed to get DGI to an investment banker, Fall '99. They did not have foresight regarding the power of the bubble. OTOH, they never screwed anyone as many companies did at the time. >> I take it you don't like cost basing your shares << I just think that the dividends are silly. But it has contributed to liquidity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next